The utilization areas of cabergoline in veterinary gynecology

dc.contributor.author	Yenilmez, Kudret
dc.contributor.author	Eren, Nihal
dc.date.accessioned	2020-12-21T12:35:10Z
dc.date.available	2020-12-21T12:35:10Z
dc.date.issued	2019-04-14
dc.description.abstract	Cabergoline is a potent dopamine agonist and a synthetic ergot derivative, and it acts by inhibiting prolactin secretion from the pituitary gland. It reduces the amount of plasma prolactin and inhibits progesterone secretion at the same time. Because of these effects, it has found a widespread area of use in the treatment of hyperprolactinemic disorders both in the human medicine and veterinary medicine.
dc.identifier.citation	Yenilmez, K. ve Eren, N. (2019). "The utilization areas of cabergoline in veterinary gynecology". Bursa Uludağ Üniversitesi Veteriner Fakültesi, 38(1), 77-81.
dc.identifier.endpage	81
dc.identifier.issn	1301-3173
dc.identifier.issue	1
dc.identifier.startpage	77
dc.identifier.uri	https://dergipark.org.tr/tr/download/article-file/764369
dc.identifier.uri	http://hdl.handle.net/11452/14516
dc.identifier.volume	38
dc.language.iso	en
dc.publisher	Bursa Uludağ Üniversitesi
dc.relation.journal	Veteriner Hekimlikte Araştırma Dergisi / Journal of Research in Veterinary Medicine
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Cabergoline
dc.subject	Veterinary
dc.subject	Gynaecology
dc.title	The utilization areas of cabergoline in veterinary gynecology
dc.type	Article